EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring the relationship between extracellular vesicles, the dendritic cell immunoreceptor, and microRNA ‐155 in an in vivo model of HIV ‐1 infection to understand the disease and develop new treatments

Julien Boucher, Gabriel Pépin, Benjamin Goyer, Audrey Hubert, Wilfried Wenceslas Bazié iD, Julien Vitry, Frédéric Barabé iD, Caroline Gilbert iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202402692rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Julien Boucher und 7 weiteren Autor:innen. Beteiligte Einrichtung: Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, Quebec, Canada. Hauptthemen laut MEDLINE: MicroRNAs, Extracellular Vesicles, HIV Infections, HIV-1. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Government | CIHR | HIV/AIDS and STBBI Research Initiative (HIV/AIDS Research Initiative), Canadian Government | CIHR | Institute of Infection and Immunity (III), HIV/AIDS and STBBI Research Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV‐1 infection induces persistent immune system activation despite antiretroviral therapy. New immunomodulatory targets might be required to restore immune competence. The dendritic cells immunoreceptor (DCIR) can bind HIV‐1 and regulate immune functions and extracellular vesicles (EVs) production. EVs have emerged as biomarkers and a non‐invasive tool to monitor HIV‐1 progression. In people living with HIV‐1, an increase in the size and abundance of EVs is associated with a decline in the CD4/CD8 T cells ratio, a key marker of immune dysfunction. Analysis of host nucleic acids within EVs has revealed an enrichment of microRNA‐155 (miR‐155) during HIV‐1 infection. Experiments have demonstrated that miR‐155‐rich EVs enhance HIV‐1 infection in vitro. A humanized NSG‐mouse model was established to assess the in vivo impact of miR‐155‐rich EVs. Co‐production of the virus with miR‐155‐rich EVs heightened the viral load and lowered the CD4/CD8 ratio in the mice. Upon euthanasia, EVs were isolated from plasma for size and quantity assessment. Consistent with findings in individuals with HIV‐1, increased EV size and abundance were inversely correlated with the CD4/CD8 ratio. Next, by using the virus co‐product with EV‐miR‐155, we tested a DCIR inhibitor to limit infection and immune damage in a humanized mouse model. DCIR inhibition reduced infection and partially restored immune functions. Finally, viral particles and various EV subtypes can convey HIV‐1 RNA. HIV‐1 RNA was predominantly associated with large EVs (200‐1000 nm) rather than small EVs (50‐200 nm). Viral loads in large EVs strongly correlated with blood and tissue markers of immune activation. The humanized mice model has proven its applicability to studying the roles of EVs on HIV‐1 infection and investigating the impact of DCIR inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsExtracellular VesiclesHIV InfectionsHIV-1Dendritic CellsReceptors, ImmunologicAnimalsMiceHumansDisease Models, AnimalViral Load

Substanzen

MicroRNAsMIRN155 microRNA, humanReceptors, ImmunologicMirn155 microRNA, mouse

Autor:innen und Institutionen

  • Axe de Recherche Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec-Université Laval, Québec, Quebec, Canada.
  • Programme de Recherche Sur les Maladies Infectieuses, Centre Muraz, Institut National de Santé Publique, Bobo-Dioulasso, Burkina Faso.
  • Département de médecine, Faculté de médecine, Université Laval, Québec, Quebec, Canada.
  • Département de Microbiologie-Infectiologie et d'Immunologie, Faculté de Médecine, Université Laval, Québec, Quebec, Canada.

ORCID-Profile: Wilfried Wenceslas Bazié, Frédéric Barabé, Caroline Gilbert

Förderung

  • Canadian Government | CIHR | HIV/AIDS and STBBI Research Initiative (HIV/AIDS Research Initiative)
  • Canadian Government | CIHR | Institute of Infection and Immunity (III)
  • HIV/AIDS and STBBI Research Initiative
  • Institute of Infection and Immunity

Zitieren

APA

Boucher, J., Pépin, G., Goyer, B., Hubert, A., Bazié, W. W., Vitry, J., Barabé, F., & Gilbert, C. (2025). Exploring the relationship between extracellular vesicles, the dendritic cell immunoreceptor, and microRNA ‐155 in an in vivo model of HIV ‐1 infection to understand the disease and develop new treatments. The FASEB Journal. https://doi.org/10.1096/fj.202402692rr

Vancouver

Boucher J, Pépin G, Goyer B, Hubert A, Bazié WW, Vitry J, et al. Exploring the relationship between extracellular vesicles, the dendritic cell immunoreceptor, and microRNA ‐155 in an in vivo model of HIV ‐1 infection to understand the disease and develop new treatments. The FASEB Journal. 2025. doi:10.1096/fj.202402692rr

BibTeX
@article{Boucher2025,
  author = {Boucher, Julien and Pépin, Gabriel and Goyer, Benjamin and Hubert, Audrey and Bazié, Wilfried Wenceslas and Vitry, Julien and Barabé, Frédéric and Gilbert, Caroline},
  title = {Exploring the relationship between extracellular vesicles, the dendritic cell immunoreceptor, and microRNA ‐155 in an in vivo model of HIV ‐1 infection to understand the disease and develop new treatments},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202402692rr}
}
Kostenlos starten →